Burke, S E <br/><br/>
Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model.  [electronic resource] 

 -  Thrombosis and haemostasis  Feb 1999 
 - 301-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arterial Occlusive Diseases--drug therapy<br/>Dogs<br/>Dose-Response Relationship, Drug<br/>Drug Evaluation, Preclinical<br/>Femoral Artery<br/>Fibrinolytic Agents--administration & dosage<br/>Hindlimb--blood supply<br/>Infusions, Intra-Arterial<br/>Infusions, Intravenous<br/>Injections, Intravenous<br/>Male<br/>Recombinant Fusion Proteins--administration & dosage<br/>Recombinant Proteins--administration & dosage<br/>Regional Blood Flow--drug effects<br/>Thrombolytic Therapy<br/>Thrombosis--drug therapy<br/>Urokinase-Type Plasminogen Activator--administration & dosage